Illumina Body Map 2
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
HNF1A | hg19_v2_chr12_+_121416489_121416552 | 0.84 | 1.4e-09 | Click! |
HNF1B | hg19_v2_chr17_-_36105009_36105060 | 0.68 | 1.8e-05 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr4_-_72649763 Show fit | 137.34 |
ENST00000513476.1
|
group-specific component (vitamin D binding protein) |
|
chr4_+_74347400 Show fit | 115.09 |
ENST00000226355.3
|
afamin |
|
chr17_-_64225508 Show fit | 102.94 |
ENST00000205948.6
|
apolipoprotein H (beta-2-glycoprotein I) |
|
chr4_+_155484103 Show fit | 90.69 |
ENST00000302068.4
|
fibrinogen beta chain |
|
chr4_-_155511887 Show fit | 89.73 |
ENST00000302053.3
ENST00000403106.3 |
fibrinogen alpha chain |
|
chr4_+_155484155 Show fit | 88.97 |
ENST00000509493.1
|
fibrinogen beta chain |
|
chr19_-_36304201 Show fit | 87.29 |
ENST00000301175.3
|
proline dehydrogenase (oxidase) 2 |
|
chr2_+_234601512 Show fit | 73.28 |
ENST00000305139.6
|
UDP glucuronosyltransferase 1 family, polypeptide A6 |
|
chr2_+_234637754 Show fit | 71.68 |
ENST00000482026.1
ENST00000609767.1 |
UDP glucuronosyltransferase 1 family, polypeptide A3 UDP glucuronosyltransferase 1 family, polypeptide A8 |
|
chr20_+_43029911 Show fit | 69.82 |
ENST00000443598.2
ENST00000316099.4 ENST00000415691.2 |
hepatocyte nuclear factor 4, alpha |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
19.7 | 276.4 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
4.2 | 266.5 | GO:0051180 | vitamin transport(GO:0051180) |
39.7 | 198.5 | GO:0070980 | biphenyl catabolic process(GO:0070980) |
14.3 | 185.5 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
34.0 | 170.1 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
7.6 | 167.5 | GO:0046415 | urate metabolic process(GO:0046415) |
16.3 | 162.7 | GO:0045959 | regulation of complement activation, classical pathway(GO:0030450) negative regulation of complement activation, classical pathway(GO:0045959) |
18.1 | 126.5 | GO:0008218 | bioluminescence(GO:0008218) |
12.2 | 122.2 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
3.7 | 118.5 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 462.6 | GO:0005615 | extracellular space(GO:0005615) |
1.8 | 461.1 | GO:0072562 | blood microparticle(GO:0072562) |
23.7 | 332.1 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.5 | 260.1 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
8.3 | 198.5 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.0 | 172.3 | GO:0005576 | extracellular region(GO:0005576) |
0.1 | 156.9 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.0 | 151.8 | GO:0005654 | nucleoplasm(GO:0005654) |
0.3 | 150.7 | GO:0030133 | transport vesicle(GO:0030133) |
0.2 | 150.0 | GO:0005759 | mitochondrial matrix(GO:0005759) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.3 | 387.9 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
1.8 | 291.9 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
1.1 | 179.7 | GO:0051087 | chaperone binding(GO:0051087) |
3.0 | 169.1 | GO:0005504 | fatty acid binding(GO:0005504) |
7.4 | 147.6 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
45.8 | 137.3 | GO:1902271 | D3 vitamins binding(GO:1902271) |
9.8 | 127.1 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.4 | 121.6 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
1.3 | 116.9 | GO:0005044 | scavenger receptor activity(GO:0005044) |
28.8 | 115.1 | GO:0008431 | vitamin E binding(GO:0008431) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 541.8 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
3.2 | 294.2 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
3.9 | 269.7 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
1.8 | 110.6 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
1.7 | 108.5 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.8 | 100.2 | PID FGF PATHWAY | FGF signaling pathway |
0.8 | 72.4 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
1.2 | 68.6 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.2 | 54.0 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.4 | 42.8 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
15.6 | 328.1 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
10.5 | 324.7 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
8.4 | 259.9 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
2.7 | 137.3 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
5.3 | 137.2 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
2.9 | 122.2 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
4.3 | 121.6 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
2.3 | 105.8 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
4.2 | 101.1 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.6 | 99.4 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |